MRD / Regn No. : SG004535 Date : 06/06/2026
Patient Name : Jay Shrestha Age & Gender : 70 Yrs. / Male
Contact No. : 9831020173 UHID :
Ht / Wt / BMI : 169 / 75 / 26.26 BP S / BP D : 142 / 75
Allergies : NKA Referred By :
   
Problem List : CVA (06/Jun/2011) | CAD (06/Jun/2026) | TYPE 2 DIABETES (06/Jun/2026) | CKD 3B (06/Jun/2026) |
Salient Investigations : POTASSIUM: 5.11 | CREATININE: 1.57 | EGFR EGLOMERULAR FILTRATION RATE: 46.70 mL/min/1.73m2 | HBA1C GLYCOSYLATED HEMOGLOBIN: 6.5 % | MICROALBUMIN CREATININE RATIO: 441.33 mcg/mg
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET TAMULOSIN 0.4 MG DUTASERIDE 0.5 MG
URIMAX D
Medicine For MAY CAUSE ERECTILE DYSFUNCTION OR LOSS OF LIBIDO 		PO 0-0-1 BEFORE DINNER
 TILL NEXT VISIT
MAY CAUSE ERECTILE DYSFUNCTION OR LOSS OF LIBIDO
2 TABLET LINAGLIPTIN 5 MG
ONDERO 5 MG
Medicine For T2DM 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
3 TABLET FINERENONE 10 MG
LYVELSA 10 MG 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 06/Dec/2026
Tests Suggested For Next Visit : CHECK SERUM POTASSIUM (WITHOUT TOURNIQUETTE),HBA1C-HPLC METHOD,RETINA CHECK UP,CREATININE
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: